Intrinsiqs

Is PMV Pharmaceuticals, Inc. overvalued?

PMV Pharmaceuticals, Inc. (PMVP) — key valuation metrics and fundamentals.

No verdict
Price
$1.27
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$67.7M
Dividend yield
0.0%
Return on equity
-110.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PMVP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.